Market Tracker

07/29 9:32am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

129.76
Delayed Data
As of Jul 28
 0.00 / 0.00%
Today’s Change
52.35
Today|||52-Week Range
140.00
+33.77%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close129.76
Today’s openn.a.
Day’s range-- - --
Volume3,295
Average volume (3 months)784,462
Market cap$10.9B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+37.70%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book10.70

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.14+1.48%
ISISIsis Pharmaceuticals...0.000.00%
ICLRICON PLC+0.23+0.31%
PRXLPAREXEL Internationa...0.000.00%
Data as of 9:31am ET, 07/29/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts